申请人:Hoffmann-La Roche Inc.
公开号:US20140303141A1
公开(公告)日:2014-10-09
The invention is concerned with triazolopyridine compounds of formula (I)
wherein R
1
, R
2
and R
3
are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit PDE10A and can be used as medicaments.
该发明涉及式(I)的三唑吡啶化合物,其中R1,R2和R3的定义如说明书和权利要求中所述,以及其生理上可接受的盐。这些化合物抑制PDE10A并可用作药物。